Abstract Title:

Vitamin C and Thiamine Are Associated with Lower Mortality in Sepsis.

Abstract Source:

J Trauma Acute Care Surg. 2020 Feb 7. Epub 2020 Feb 7. PMID: 32039973

Abstract Author(s):

Saskya Byerly, Joshua Parreco, Hahn Soe-Lin, Jonathan Parks, Eugenia E Lee, Ilya Shnaydman, Alejandro Mantero, D Dante Yeh, Nicholas Namias, Rishi Rattan

Article Affiliation:

Saskya Byerly


INTRODUCTION: The efficacy of vitamin C (VitC) and thiamine (THMN) in patients admitted to the intensive care unit (ICU) with sepsis is unclear. The purpose of this study was to evaluate the effect of VitC and THMN on mortality and lactate clearance in ICU patients. We hypothesized that survival and lactate clearance would be improved when treated with thiamine and/or vitamin C.

METHODS: The Philips eICU database version 2.0 was queried for patients admitted to the ICU in 2014-2015 for≥48 hours and patients with sepsis and an elevated lactate≥2.0 mmol/L. Subjects were categorized according to the receipt of VitC, THMN, both, or neither. The primary outcome was in-hospital mortality. Secondary outcome was lactate clearance defined as lactate<2.0 mmol/L achieved after maximum lactate. Univariable comparisons included age, gender, race, Acute Physiology Score III, APACHE IVa score, SOFA, surgical ICU admission status, intubation status, hospital region, liver disease, vasopressors, steroids, VitC and THMN orders. Kaplan-Meier curves, logistic regression, propensity score matching and competing risks modeling were constructed.

RESULTS: Of 146,687 patients from 186 hospitals, 7.7% (n=11,330) were included. Overall mortality was 25.9% (n=2,930). Evidence in favor of an association between VitC and/or THMN administration and survival was found on log rank test (all p<0.001). After controlling for confounding factors, VitC (AOR:0.69[0.50-0.95]) and THMN (AOR:0.71[0.55-0.93]) were independently associated with survival and THMN was associated with lactate clearance (AOR:1.50 [1.22-1.96]). On competing risk model VitC (AOR:0.675 [0.463-0.983]), THMN (AOR:0.744 [0.569-0.974]), and VitC+THMN (AOR:0.335 [0.13-0.865]) were associated with survival but not lactate clearance. For subgroup analysis of patients on vasopressors, VitC+THMN were associated with lactate clearance (AOR:1.85 [1.05-3.24]) and survival (AOR:0.223 [0.0678-0.735]).

CONCLUSIONS: VitC+THMN is associated with increased survival in septic ICU patients. Randomized, multicenter trials are needed to better understand their effects on outcomes.

LEVEL OF EVIDENCE: Therapeutic Study, Level IV.

Study Type : Human Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.